Recent Advances on Chitosan Nanoparticles

 

Aamir Nazir1, Neha Kumari1*, Nitan Bharti Gupta2, Rajesh Gupta2,

Ashima Chandel2, Abi C. Varghese2

1Department of Pharmaceutics, Sri Sai College of Pharmacy, Badhani, Pathankot 145001, Punjab, India.

2Chandigarh University of Pharma Science (UIPS), Chandigarh - Ludhiana Highway,

Gharuan, Mohali, Punjab, India.

*Corresponding Author E-mail: neha91sn@gmail.com

 

ABSTRACT:

The focal point of this survey is to give an outline of the chitosan based nanoparticles for different non-parenteral applications and furthermore to put a focus on flow research including supported delivery and mucoadhesive chitosan measurement structures. Chitosan is a biodegradable, biocompatible polymer viewed as safe for human dietary use and endorsed for wound dressing applications. Chitosan has been utilized as a transporter in polymeric nanoparticles for drug conveyance through different courses of organization. Chitosan has synthetic useful gatherings that can be adjusted to accomplish explicit objectives, making it a polymer with an enormous scope of expected applications. Nanoparticles (NP) ready with chitosan and chitosan subsidiaries ordinarily have a positive surface charge and mucoadhesive properties to such an extent that can hold fast to bodily fluid films and delivery the medication payload in a supported delivery way. Chitosan-based NP have different applications in non-parenteral medication conveyance for the therapy of malignant growth, gastrointestinal illnesses, aspiratory sicknesses, drug conveyance to the mind and visual contaminations which will be exemplified in this survey. Chitosan shows low poisonousness both in vitro and some in vivo models. This survey investigates ongoing exploration on chitosan based NP for non-parenteral medication conveyance, chitosan properties, adjustment, poisonousness, pharmacokinetics and preclinical examinations.

 

KEYWORDS: Chitosan, Polymeric Nanoparticles, Mucoadhesive, Biodegredable, Oral drug delivery.

 

 


INTRODUCTION:

The mucosal course is acquiring consideration for non-obtrusive medication conveyance by means of the oral, nasal,  aspiratory or vaginal courses1. Simultaneously, nanoparticle innovation has likewise come to the front line as a suitable medication conveyance technique, introducing openings for controlled delivery, insurance of dynamic parts from enzymatic or ecological debasement and restricted maintenance. Nanoparticle manufacture techniques are promptly adaptable and material to an expansive scope of medications. Of all the nanoparticle drug conveyance draws near, polymeric nanoparticles have acquired critical significance as they are biodegradable, biocompatible and in light of the fact that plan techniques are all the more generally accessible; the scope of utilizations has been growing to incorporate an assortment of substance drug classes and measurements structures2. Chitosan-based NP are especially fitting for the mucosal course, with their low harmfulness, mucoadhesion and tunable actual properties. Models will be given of chitosan-based nanoparticles utilized for the therapy of malignant growth, gastrointestinal sicknesses, aspiratory illnesses, drug conveyance to the cerebrum and visual contaminations.

 

CHITOSAN:

Chitosan is the most important derivative of chitin, produced by removing the acetate moiety from chitin as shown in (Figure 1).


 

Figure 1. Deacetylation of chitin to chitosan

 

Figure 2. Schematic illustration of the presumed mechanism of transcellular and paracellular transport of chitosan NP across the epithelium.

 


It is gotten from shellfish shells like those from prawns or crabs, just as from the cell dividers of growths. It is a normally happening polysaccharide, cationic, profoundly essential, mucoadhesive biocompatible polymer and endorsed by the U.S. FDA for tissue designing and medication conveyance. Chitin from regular sources is tracked down bound to proteins and minerals, which should be eliminated before readiness of chitosan, however cycles of fermentation and alkalization. Filtered chitin is then N-deacetylated to chitosan. This cycle can be altered to control the finished result properties [including sub-atomic weight and pKa (6–7.5) by controlling the level of deacetylation with elements, for example, response conditions (focus, proportions of chitin to salt, temperature), chitin source and degree of the response, for instance. While these substance processes are well close by for modern processors, research is continuous to all the more completely create adaptable organic, enzymatic orhybrid techniques, for example, those utilizing Microorganisms3. Chitosan acts an infiltration enhancer by opening the tight intersections of the epithelium. Chitosan works with both paracellular and transcellular transport of medications as demonstrated in (Figure 2). Chitosan interfaces with bodily fluid (adversely charged) to frame a complex by ionic or hydrogen holding just as however hydrophobic cooperations. The pKa of the essential amine of chitosan is ~6.5, contingent upon the level of N-deacetylation. This gathering likewise adds to the dissolvability of chitosan in acidic pH conditions and the fractional balance of this essential amine may likewise clarify why chitosan has been accounted for to total at impartial to high pH4.

 

NANOPARTICLES:

Nanoparticles are the solid colloidal particles with distances across going from 1-1000nm.\"Nano\" still up in the air from Latin word, which suggests eclipse. Nano measure insinuates one thousand millionth of a meter. \"Nanotechnology\" for the initial go through was used by Prof. Taniguchi in 1974. In 1986 Eric Drexler\'s advanced the creative possible results of nanotechnology and especially said the \"Dark Goo\" ponders. By then in 2000 Public Nanotechnology Drive (NNI) was developed by US President Bill Clinton. Nanoparticles are encompassing us as of now and have been all around us all of us mankind\'s set of experiences. The contemplations and thoughts behind nanoscience and nanotechnology started with a conversation entitled \"There\'s A lot of Room at the Bottom\" by physicist Richard Feynman in 1959. In this conversation, he explored the believability of controlling material at the nano scale by imagining the whole of the Reference book Britannica made on the pioneer out of a stick moreover depicted a methodology through which analysts would prepared to control the person particle then again molecule as an even more skilled instrument of sensible science than those used around then, at that point5. The craftsmans were known to be the principle nanotechnologists they make Archaic Stained by getting gold nanoparticles in the \'glass network\' with a particular ultimate objective to make the ruby red overshadowing and silver nanoparticles. Deruta Ceramicists were made by Italians; they conveyed iridescent or metallic coatings by using silver and copper particles. The Lycurgus Cup was made by the Romans with gold and silver nanoparticles. It appears to be green in mirrored light and red in communicated light. Be that as it might, presently a day\'s nanoparticles go similarly a drug carrier in which the powerful fixing is separated, dispersed, entrapped, encapsulated, adsorbed or artificially joined. Over the period various applications have been made using nanoparticles. Today nanoparticles go similarly a drug conveyor in which the unique fixing may be dissipated, separated, encapsulated, caught, adsorbed or falsely joined. Nanoparticles join nanospheres, nanocapsules, liposomes, dendrimers, polymeric nanoparticles and solid lipid nanoparticles. Among these polymeric nanoparticles may offer one more progress in prescription disclosure. They can be set up from either produced polymer or normal polymer. Among customary polymers chitosan are comprehensively examined for biomedical furthermore, drug applications6.

 

Properties of Chitosan Nanoparticles:

Chitosan Nanoparticles has been researched as a material of choice to shape nanoparticles for the latest decade. The properties of chitosan have been updated by making their nanoparticles. The original person of NP for their little size and quantum gauge effect could make CSNP show common activities They are fundamental and unassuming to make and increase and have phenomenal size and huge surface-to-volume extent. They are mucoadhesive and hydrophyllic in nature due to which they give extraordinary security to epitomized calm, increase its opportunity time and dauntlessness in the body. Thusly, they are suitable to an overall characterization of prescriptions; little particles, proteins and polynucleotides. The benefits of epitomizing dynamic experts in a polymer structure consolidate their protection from the including medium or taking care of conditions and their controlled release.

 

Toxicity of chitosan nanoparticles:

Chitosan Nanoparticles is insisted as a non-hazardous, biocompatible polymer by US Food and Medication Organization (FDA) for wound dressing. The LD50 of CS in mice after oral association is 16g/kg body weight, which is basically comparable to nuclear family sugar or salt. No indications were represented in human up to 4.5 g/day oral association of CS. In any case, when taken reliably for a long time, it demonstrated delicate infection and stoppage in people. Notwithstanding the way that CS alone is viewed as okay for oral association, its properties might change absolutely upon mixture adjustment. Plus, it is perceived that the pharmacokinetic properties of a prescription or excipient change altogether when joined into a nanoparticulate system. Thusly, there in vivo fate is picked by the size, charge and surface changes of the NPs. This accordingly can change the harmful quality profile of the actual NP, as these properties sway the manner in which the NPs speaks with particular kinds of cells, subsequently modifying their telephone take-up, ingestion through the GIT, tissue spread and discharge. This is the explanation that the generally saw as protected (GRAS) status of CS doesn't significantly impact nanoparticulate definitions and essentially depends on the conditions of proposed use8. What\'s more, nuclear weight and level of deacetylation of chitosan impacts the pharmacokinetic properties and risk. Along these lines, each and every auxiliary should be overviewed independently both in the free shape and nanoparticulate outline.

 

Preparation of Chitosan Nanoparticles:

Ionotropic gelation, microemulsion, emulsification dissolvable dispersion and emulsion based dissolvable vanishing are the most well-known strategies to get ready chitosan-based nanoparticles. Use of less natural dissolvable and lesser power are a portion of the principle benefits the greater part of these strategies offer. The key attributes that are found to influence the molecule size and surface charge of chitosan NPs arranged by these techniques are atomic weight and the level of acetylation of the chitosan. A portion of the components by which medications are captured inside the polymeric network are electrostatic connection, hydrogen holding and hydrophobic associations. Medication stacking and discharge are not by any means the only key elements, notwithstanding. The planned utilization of the nanoparticles and the physiological climate at the site of organization should be considered, for example not just ionic strength, or the presence of salts, chemicals and proteins yet in addition pH soundness (think about the milieu of the eye versus the GI lot). Luckily, we currently have various definition strategies to look over.

 

a) Ionotropic Gelation:

This is a simple technique where the chitosan solution (positively charged) is dissolved in acetic acid or any polyanionic solution (negatively charged) with or without a stabilizing agent such as poloxamer. Nanoparticles are readily formed due to complexation between positive and negative charged species during mechanical stirring at room temperature, resulting in separation of chitosan in spherical particles of different sizes and surface charges. Generally, the reported particle size ranges from 20 to 200 and 550 to 900 nm. Chitosan-TPP/vitamin C nanoparticles were prepared via ionotropic gelation between the positively charged amino groups of chitosan-TPP and the vitamin C, with constant stirring at room temperature for just 1 h9,10. A few advantages of ionotropic gelation include: the processing conditions are mild and it uses an aqueous environment, low toxicity and little chance of altering the chemistry of the drug to be encapsulated. The main disadvantages of this method are its poor stability in acidic conditions and difficulty in entrapping high molecular weight drugs2,11.

 

b) Complex Coacervation Method:

Coacervation is a strategy of isolating round particles by blending electrostatically determined fluids. DNA-chitosan nanoparticles are framed by coacervation of the emphatically charged amine gatherings of chitosan and the adversely charged DNA phosphate bunches12,13. Capture productivity and medication discharge are administered by the sub-atomic load of the two polymers. A benefit of intricate coacervation is that the interaction can be totally acted in a watery arrangement at low temperature. This gives a superior shot at saving the action of the epitomized substances. The principle burdens of this technique are the helpless security of the NPs, low medication stacking and crosslinking of the complex by a synthetic reagent, for example, harmful glutaraldehyde is important. In the polyelectrolyte complex (PEC) technique, an anionic answer (for instance, dextran sulfate DNA arrangement) is added to the cationic polymer (e.g., chitosan arrangement broke down in acidic corrosive, gelatin and polyethylenimine), under mechanical blending at room temperature followed by charge balance. Benefits include: the technique is basic, there is a shortfall of unforgiving conditions and the nanoparticles structure unexpectedly. Low sub-atomic weight water-solvent chitosan (LMWSC) nanocarriers were created by the PEC technique for insulin, bringing about insulin-stacked chitosan NPs with a detailed mean breadth of ~200nm and supported delivery profile in vitro9.

 

c) Microemulsion Method:

In this technique, chitosan in acidic corrosive arrangement and glutaraldehyde are added to a surfactant in a natural dissolvable like hexane. This combination is kept on persistent blending at room temperature, permitting the nanoparticles to shape for the time being as the cross-connecting process is finished. Natural dissolvable is then eliminated by dissipating under low tension. The item now has overabundance surfactant which can be eliminated by encouraging with calcium chloride followed by centrifugation. The last nanoparticle suspension is then dialyzed and afterward lyophilized14. An exceptionally limited size dispersion is seen with this technique and the size can be constrained by the convergence of glutaraldehyde in the arrangement of the NPs. This technique brings about arrangement of little estimated nanoparticles15. A few inconveniences with this technique incorporate use of natural dissolvable, an extensive cycle and a perplexing washing step.

 

d) Emulsification Solvent Diffusion Method:

An o/w emulsion is ready by blending natural dissolvable into an answer of chitosan with stabilizer under mechanical mixing followed by high tension homogenization16. Size scope of 300–500nm could be accomplished with this technique. Polymer precipitation happens when a lot of water is added to the emulsion, shaping nanoparticles. This technique is most appropriate for capture of hydrophobic medications, for which the ensnarement effectiveness is viewed as high. The significant detriment of the technique incorporates use of high shear powers.

 

e) Emulsion Based Solvent Evaporation Method:

This technique is a slight change of the above strategy however dodges high shear powers. Molecule size of under 300nm can be accomplished with this technique. An emulsion is ready by adding natural dissolvable to an answer of chitosan with surfactant followed by ultrasonication. The emulsion shaped is then added to a surfactant arrangement and permitted to mix until the natural dissolvable is vanished, framing nanoparticles. The NP are then washed and centrifuged on numerous occasions to eliminate overabundance surfactant followed, by lyophilization to accomplish freeze-dried nanoparticles17.

 

f) Reverse Micellar Method:

The surfactant is broken up in a natural dissolvable followed by the expansion of chitosan, drug and crosslinking specialist, under steady for the time being vortex blending. The natural dissolvable is vanished outcomes in line of straightforward dry mass, then, at that point, the last option is scattered in water and afterward an appropriate salt is added for encouraging the surfactant. An extremely limited size range nanoparticle is seen and natural solvents are utilized. Doxorubicin-dextran form stacked chitosan nanoparticles were ready by switch micellar technique. The surfactant utilized in this technique was sodium bis (ethyl hexyl) sulfosuccinate (AOT) was disintegrated in n-hexane. The NP are shaped by adding fluid smelling salts and 0.01% glutaraldehyde to AOT arrangement, 0.1% chitosan in acidic corrosive, doxorubicin–dextran form upon constant blending at room temperature18,19.

 

CONCLUSION:

Because of its versatility, chitosan offers a wide range of possible applications in drug administration, including the GIT, nasal, and pulmonary routes, as discussed in this review. Chitosan NP can effectively distribute drugs to specific areas by keeping them locally, allowing for a longer period of absorption. Mucoadhesion and mucosal adhesion Chitosan improves absorption, allowing medications to be delivered directly from the nose to the body. brain. Similarly, chitosan NP can successfully address lung infections and colon disorders on a local level. RylomineTM, a chitosan-based nasal morphine formulation, is now in Phase 2 clinical studies Phase 3 clinical trials in the United States (UK and EU). When it hits the market, we expect it to pave the way for comparable products in the near future, as well as aid in the detection of any unexpected consequences in humans22. While not particularly discussed here, we anticipate further advancements in the utilisation of chitosan nanoparticles in cancer theranostics, dermatologic applications, and other fields20-22. Targeted parenteral medication delivery systems With the introduction of new ways for conquering obstacles, enhanced formulation strategies for a wider array of medicines and even improved chitosan limitations We hope to see more chitosan research in the coming future, particularly in nasal and oral macromolecules. pulmonary drug administration We believe that future research on chitosan nanoparticles made using chitosan will be fruitful. Toxicity tests on chitosan derivatives or chitosan will also be conducted in humans.

 

REFERENCES:

1.      Rampino, A. Borgogna, M. Blasi, P. Bellich, B. Cesàro, A. Chitosan nanoparticles: Preparation, size evolution and stability. Int. J. Pharm. 2013; 455: 219–228.doi.org/10.1016/j.ijpharm.2013.07.034.

2.      Nagpal, K. Singh, S.K. Mishra, D.N. Chitosan Nanoparticles: A Promising System in Novel Drug Delivery. Chem. Pharm. Bull. 2010; 58 : 1423–1430.doi.org/ 10.1248/cpb.58.1423.

3.      Vårum, K.M. Ottøy, M.H. Smidsrød, O. Water-solubility of partially N-acetylated chitosans as a function of pH: Effect of chemical composition and depolymerisation. Carbohydr. Polym. 1994; 25: 65–70.Doi.org/10.1016/0144-8617(94)90140-6.

4.      Chen, M.C, Mi, F.L. Liao, Z.X. Hsiao, C.W. Sonaje, K. Chung, M.F.; Hsu, L.W.; Sung, H.W. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules: Adv. Drug Deliv. Rev. 2013; 65: 865–879.Doi.org/10.1016/j.addr.2012.10.010.

5.      Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An Overview of Chitosan Nanoparticles and its Applications in Non Parentral Drug Delivery. Pharmaceutics. 2017; 53: 34-43. Doi.org/10.3390/pharmaceutics9040053.

6.      Frank Alexis, Eric M. Pridgen, Robert Langer, and Omid C. Farokhzad; Nanoparticle Technologies for Cancer Therapy; M. Scha¨fer- Korting (ed.), Drug Delivery, Handbook of Experimental Pharmacology 197; Springer-Verlag Berlin Heidelberg 2010. Doi.org/10.1016/0168-3659(93)90097-O.

7.      Baldrick, P. 2010.The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol.  Pharmacol.,56:290–299. doi.org/10.1016/S0168-3659(01)00486-2.

8.      Kean, T, and Thanou M. 2010. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev., 62: 3–11.doi.org/10.1067/ cpb.58.14232.2010.08.056

9.      Alishahi, A. Mirvaghefi, A. Tehrani, M.R. Farahmand, H.; Koshio, S.; Dorkoosh, F.A.; Elsabee, M.Z. Chitosan nanoparticle to carry vitamin C through the gastrointestinal tract and induce the non-specific immunity system of rainbow trout (Oncorhynchus mykiss). Carbohydr. Polym. 2011; 86: 142–146. doi.org/10.1016/j.carbpol.2011.04.028.

10.   Hembram, K.C. Prabha, S.; Chandra, R. Ahmed, B.; Nimesh, S. Advances in preparation and characterization of chitosan nanoparticles for therapeutics: Artif. Cells Nanomed. Biotechnol. 2014; 1401: 1–10. doi.org/10.3109/21691401.2014.948548

11.   Gonçalves, I.C. Henriques, P.C. Seabra, C.L. Martins, M.C.L. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection: Expert Rev. Anti. Infect. Ther. 2014; 12: 981–992.Doi.org/10.1586/14787210.2014.930663

12.   Zhao, K. Shi, X. Zhao, Y. Wei, H. Sun, Q.; Huang, T. Zhang, X.Wang, Y. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.: Vaccine 2011; 29:8549–8556. doi.org/10.1016/j.vaccine.2011.09.029.

13.   Zhuo, Y.; Han, J. Tang, L.Liao, N. Gui, G.-F.; Chai, Y.-Q.; Yuan, R. Quenching of the emission of peroxydisulfate system by ferrocene functionalized chitosan nanoparticles: A sensitive “signal off” electrochemiluminescence immunosensor: Sens. Actuators B Chem. 2014; 192: 791–795. Doi.org/10.1016/j.snb.2013.11.032.

14.   Maitra, A. Ghosh, P.K. De, T.K. Sahoo, S.K. Process for the Preparation of Highly Monodispersed Polymeric Hydrophilic Nanoparticles. US 5874111 A, 7 January 1999.doi.org/10.2147/nano.2006.1.2.181

15.   Wang, Y. Wang, X. Luo, G.; Dai, Y. Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system: Bioresour. Technol. 2008; 99: 3881–3884.doi.org/10.1016/j.biortech.2007.08.017.

16.   El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm. 2002; 249: 101–108.

17.   Zeinab Sadat, S. Hamed, S.-K. Mohammad, I. Mohammad, A.; Azizollah, N. Exploring the effect of formulation parameters on the particle size of carboxymethyl chitosan nanoparticles prepared via reverse micellar crosslinking: J. Microencapsul. 2017; 34: 270–279.doi.org/10.1080/02652048.2017.1321047.

18.   Liu, C. Tan, Y. Liu, C. Chen, X. Yu, L. Preparations, characterizations and applications of Chitosan-based nanoparticles. J. Ocean Univ. China 2007; 6: 237–243.doi.org/10.1007/s11802-007-0237-9

19.   Mitra, S. Gaur, U. Ghosh, P.C. Maitra, A.N. Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release 2001; 74: 317–323.doi.org/10.1016/S0168-3659(01)00342-X.

20.   Bellich, B. D’Agostino, I. Semeraro, S. Gamini, A. Cesàro, A. “The good, the bad and the ugly” of chitosans. Mar. Drugs 2016; 14: 99. doi.org/10.3390/md14050099.

21.   Key, J. Park, K. Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy. Int. J. Mol. Sci. 2017; 18: E594.doi.org/10.3390/ijms18030594.

22.   Swierczewska, M. Han, H.S. Kim, K. Park, J.H.; Lee, S. Polysaccharide-based nanoparticles for theranostic nanomedicine. Adv. Drug Deliv. Rev. 2016; 99 Pt A: 70–84. doi.org/10.1016/j.addr.2015.11.015.

 

 

 

Received on 28.05.2022         Modified on 26.09.2022

Accepted on 22.12.2022   ©Asian Pharma Press All Right Reserved

Asian J. Pharm. Res. 2023; 13(3):158-162.

DOI: 10.52711/2231-5691.2023.00030